drugset / Trial / NCT00357019

Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis

NCT00357019 ↗

Phase 4 Completed Laboratoires Thea
RandomizedParallel-groupOpen-labelTreatment

Summary

To assess the clinical and biological efficacity of preservative free NAAGA eyes drops in vernal keratoconjunctivitis

Timeline

Start
2001-04
Primary completion
—
Completion
2002-10

Outcome

Met primary endpoint

paper At all time points, ECP tear levels were significantly reduced in the NAAGA compared with the LEVO group (p = 0.023). PMID 17585003 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetyl-aspartyl-glutamate Unknown — Topical